Phase I Open Label Trial of Intraperitoneal Paclitaxel (IPP) in Combination with Intravenous Cisplatin (C) and Oral Capecitabine (X) in Patients with Advanced Gastric Cancer and Peritoneal Metastases

N Abbas, S Vatandoust, T Bright, AC Roy, J Bull, A Scott-Hoy, D Watson, S Gan, CS Karapetis

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)56
JournalAsia-Pacific Journal of Clinical Oncology
Issue numberS3
Publication statusPublished - 18 Jul 2018
EventMedical Oncology Group of Australia Incorporated Annual Scientific Meeting: New Directions in Personalised Cancer Therapy - Adelaide Convention Centre, Adelaide, Australia
Duration: 1 Aug 20183 Aug 2018

Cite this